References
- Hart LG, Deyo RA, Cherkin DC. Physician office visits for low back pain: frequency, clinical evaluation, and treatment patterns from a US national survey. Spine 1995;20:11–9
- Feuerstein M, Marcus SC, Huang GD. National trends in nonoperative care for nonspecific back pain. Spine J 2004;4:56–63
- Cherkin DC, Wheeler KJ, Barlow W, et al. Medication use for low back pain in primary care. Spine 1998;23:607–14
- Goetzel RZ, Hawkins K, Ozminkowski RJ, et al. The health and productivity cost burden of the ‘top 10’ physical and mental health conditions affecting six large US employers in 1999. J Occup Environ Med 2003;45:5–14
- Frymoyer JW, Cats-Baril WL. An overview of the incidences and costs of low back pain. Orthop Clin North Am 1991;22:263–71
- Childers MK, Borenstein D, Brown RL, et al. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial. Curr Med Res Opin 2005;21:1485–93
- Prevalence of disabilities and associated health conditions among adults – United States, 1999. MMWR Morb Mortal Wkly Rep 2001;50:120–5
- Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther 2004;26: 1355–67
- Boyles WF, Glassman JM, Soyka JP. Management of acute musculoskeletal conditions: thoracolumbar strain or sprain: a double-blind evaluation comparing the efficacy and safety of carisoprodol with diazepam. Todays Ther Trends 1983;1–16
- Katz WA, Dube J. Cyclobenzaprine in the treatment of acute muscle spasm: review of a decade of clinical experience. Clin Ther 1988;10:216–28
- Patel AT, Ogle AA. Diagnosis and management of acute low back pain. Am Fam Physician 2000;61:1779–90
- Burton AK, Erg E. Back injury and work loss: biomechanical and psychosocial influences. Spine 1997;22:2575–80
- Rollings HE, Glassman JM, Soyka JP. Management of acute musculoskeletal conditions – thoracolumbar strain or sprain: a double-blind evaluation comparing the efficacy and safety of carisoprodol with cyclobenzaprine hydrochloride. Curr Ther Res 1983;34:917–28
- MedPointe Pharmaceuticals, Somerset, New Jersey. US prescribing information
- Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manag 2004;28:140–75
- Gready DM. Use of carisoprodol in symptomatic therapy of painful muscle spasm. Ind Med Surg 1965;34:617–9
- Hindle III TH. Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome. Calif Med 1972;117:7–11
- Littrell RA, Hayes LR, Stillner V. Carisoprodol (Soma): a new and cautious perspective on an old agent. South Med J 1993;86:753–6
- World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at http://www.wma.net/e/policy/pdf/17c.pdf [accessed January 25, 2007]
- Roland M, Morris R. A study of the natural history of low-back pain. Part II: development of guidelines for trials of treatment in primary care. Spine 1983;8:145–50
- Borenstein DG, Korn S. Efficacy of a low-dose regimen of cyclobenzaprine hydrochloride in acute skeletal muscle spasm: results of two placebo-controlled trials. Clin Ther 2003;25:1056–73
- Browning R, Jackson JL, O’Malley PG. Cyclobenzaprine and back pain: a meta-analysis. Arch Intern Med 2001;161:1613–20
- Staiger TO, Paauw DS, Deyo RA, et al. Imaging studies for acute low back pain: when and when not to order them. Postgrad Med 1999;105: 161–6, 171
- Connelly C. Patients with low back pain: how to identify the few who need extra attention. Postgrad Med 1996;100: 143–50, 155
- Bigos S, Bowyer O, Braen G, et al. Acute low back problems in adults: assessment and treatment. Quick reference guide for clinicians. No. 14. Rockville (MD): Agency for Health Care Policy and Research (Public Health Service). 1994; AHCPR publication 95–0643